Mostafa Maghraby: Day 3 vs. Day 5 Embryo Transfer – Which Is Better?
Mostafa Maghraby, Embryologist, IVF and ICSI Specialist at Al-Amal Fertility Centre, shared on LinkedIn:
“Day 3 vs. Day 5 Embryo Transfer: Which Is Better?
One of the important decisions in IVF is determining when an embryo should be transferred.
Should we transfer an embryo on Day 3, at the cleavage stage, or continue culture until Day 5, when it may reach the blastocyst stage?
The answer is not always straightforward.
Day 3 Transfer – Cleavage Stage
At this stage, embryos are typically assessed based on cell number, blastomere symmetry, and the degree of fragmentation.
Potential advantages include:
- Earlier transfer.
- An option when extended culture may be challenging or when the number of available embryos is limited.
Day 5 Transfer – Blastocyst Stage
By Day 5, embryos that continue developing may reach the blastocyst stage.
Potential advantages include:
- Additional information about developmental progression.
- Better opportunities to differentiate embryos based on blastocyst morphology.
- Potential for improved embryo selection in appropriately selected cases.
Does Day 5 always mean better outcomes?
No.
Extended culture does not guarantee a higher chance of live birth for every patient. Some embryos may stop developing before reaching the blastocyst stage, and the optimal strategy depends on the individual clinical situation.
Factors such as embryo number and development, patient history, laboratory performance, and clinical recommendations all matter.
The goal is not simply to reach Day 5.
The goal is to choose the strategy that best serves each patient’s circumstances.
Because in IVF, the best decision is not always the same for every case.”

Other articles featuring Mostafa Maghraby on Fertility News.
-
Oct 17, 2026, 16:462 Weeks To Contribute to the FIGO Montréal 2027 Programme
-
Oct 17, 2026, 16:45Pauliina Valpas: 2nd Reflection from the AIFertility Conference
-
Oct 17, 2026, 16:44Barb Collura: “Advocacy 101” Master Class Workshop at the ASRM Congress
-
Oct 17, 2026, 16:41Pregnancy and Infant Loss Awareness Month – Egg Donor and Surrogate Solutions
-
Oct 17, 2026, 16:38Mauro Francesco Pio Maiorano: Why Fertility Preservation Matters Before Gonadotoxic Treatment
-
Oct 17, 2026, 16:36Felicity Jehu-Appiah: Exploring Fertility Treatment Abroad?
-
Oct 17, 2026, 16:33Stanka Matic: Reproductive Health Is Overall Health
-
Oct 17, 2026, 16:30How Do You Scale a Fertility Business While Keeping Its Purpose? – The International Fertility Forum
-
Oct 17, 2026, 16:29Emily S. Jungheim Receives Excellence in Research and Innovation Award – Loyola University Chicago Stritch School of Medicine
